International Vaccine Institute

This study tests a new oral cholera vaccine (Biovac OCV-S) in about 2,824 healthy people aged 1 to 45, including adults living with HIV. The goal is to see if the new vaccine triggers a strong immune response and is as safe as an already-approved vaccine (Euvichol-Plus). Particip…

This study tests a new cholera vaccine (called OSP:rTTHc) in about 390 healthy adults and children aged 1 to 45 living in areas where cholera is common. The goal is to see if the vaccine is safe and triggers a strong immune response, either as a single shot or two doses. Results …

This study looks at whether the malaria vaccine (R21/Matrix-M) can also lower the risk of invasive non-typhoidal Salmonella (iNTS) disease in children under 5. Researchers will compare vaccinated and unvaccinated children who come to health centers with fever in the Democratic Re…